← Back to Search

Vivity IOL Group for Pseudophakia

N/A
Recruiting
Led By Morgan Micheletti, MD
Research Sponsored by Berkeley Eye Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 weeks post operatively
Awards & highlights
No Placebo-Only Group

Summary

This trial studies how well a special lens called the Vivity IOL works for patients who had previous eye surgery for nearsightedness and are now having cataract surgery. The lens aims to improve vision at various distances by focusing light more accurately.

Eligible Conditions
  • Pseudophakia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 weeks post operatively
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 weeks post operatively for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Binocular Best Corrected Distance Visual Acuity
Secondary study objectives
Binocular distance, intermediate, and near visual acuity
Intraocular Lens Satisfaction (IOLSAT) questionnaire
Monocular vision
+3 more
Other study objectives
Any spherical aberration changes pre cataract surgery and post cataract surgery
Binocular BCDVA under mesopic room lighting conditions
Binocular defocus curve
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Vivity IOL GroupExperimental Treatment6 Interventions
Patients with bilateral implantation of Vivity IOLs.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Visual Acuity
2022
N/A
~450
Defocus Curve
2021
N/A
~320

Find a Location

Who is running the clinical trial?

Berkeley Eye CenterLead Sponsor
4 Previous Clinical Trials
963 Total Patients Enrolled
3 Trials studying Pseudophakia
756 Patients Enrolled for Pseudophakia
Morgan Micheletti, MDPrincipal InvestigatorBerkeley Eye Center
4 Previous Clinical Trials
963 Total Patients Enrolled
3 Trials studying Pseudophakia
756 Patients Enrolled for Pseudophakia
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top